Examkin

Soru

Zorluk: ZorSubstance-Related and Addictive Disorders

Paramedics bring a 27-year-old man to the emergency department after he was found unresponsive in an alley. On arrival, his blood pressure is 105/65 mmHg, pulse is 55/min, and respiratory rate is 5/min. Oxygen saturation is 78% on room air. Physical examination reveals pinpoint pupils and cyanosis of the lips. The patient is accompanied by his brother, who reports that the patient has struggled with prescription opioid misuse for years and recently transitioned to injecting street drugs. Following initial acute stabilization, the patient regains consciousness, becomes tearful, and strongly requests to start medication-assisted treatment for his addiction today. Arrange the following management steps in the most appropriate chronological sequence for this patient.

  1. 1Administer intravenous naloxone and provide bag-valve-mask ventilation.
  2. 2Monitor closely for recurrent respiratory depression for at least 2 to 4 hours.
  3. 3Wait for the development of objective mild-to-moderate opioid withdrawal symptoms.
  4. 4Administer the initial induction dose of sublingual buprenorphine.
  5. 5Titrate to a stable buprenorphine-naloxone maintenance dose and arrange outpatient addiction care.

Cevap

The correct chronological sequence is: 1) Administer intravenous naloxone and provide bag-valve-mask ventilation; 2) Monitor closely for recurrent respiratory depression for at least 2 to 4 hours; 3) Wait for the development of objective mild-to-moderate opioid withdrawal symptoms; 4) Administer the initial induction dose of sublingual buprenorphine; 5) Titrate to a stable buprenorphine-naloxone maintenance dose and arrange outpatient addiction care.
The management of opioid overdose transitioning into medication-assisted treatment follows a strict physiological sequence. First, immediate life threats must be addressed by reversing respiratory depression with naloxone and providing airway support. Because naloxone's half-life is significantly shorter than most illicit opioids, the patient must be closely monitored for recurrent overdose. Once the patient is stabilized and the full opioid agonist begins to naturally clear, the patient will enter spontaneous withdrawal. It is critical to wait for objective signs of mild-to-moderate withdrawal before administering buprenorphine. Buprenorphine is a partial mu-opioid agonist with very high receptor affinity; if given too early, it will displace remaining full agonists and cause severe precipitated withdrawal. After successful induction, the patient is transitioned to maintenance therapy and outpatient follow-up to prevent relapse.

Adım Adım Çözüm

1
Reverse opioid toxicity
Patient regains respiratory drive and consciousness.
Severe respiratory depression is life-threatening and requires immediate mu-opioid receptor antagonism.
2
Observe for resedation
Patient is monitored safely as naloxone's effects wane.
Naloxone has a significantly shorter half-life than most illicit full opioid agonists.
3
Assess for spontaneous withdrawal
Confirmation of mild-to-moderate withdrawal.
Ensures full agonists have sufficiently cleared from mu-opioid receptors to safely initiate partial agonist therapy.
4
Initiate buprenorphine induction
Patient receives first dose of partial agonist.
Relieves withdrawal symptoms and cravings without precipitating acute withdrawal, given the proper timing.
5
Establish maintenance and outpatient care
Patient is stabilized on long-term medication-assisted treatment.
Prevents relapse, manages chronic cravings, and provides psychosocial support for long-term recovery.

Anahtar Kavram

The chronological management of opioid overdose transitions from acute life-saving reversal with naloxone and monitoring, to waiting for spontaneous withdrawal, followed by buprenorphine induction and long-term maintenance.
Bu soruyu puanla

Konular

Substance-Related and Addictive Disorders

Bu konudan daha fazla soru